Aspiriant LLC’s Paychex PAYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.02M | Sell |
11,107
-10
| -0.1% | -$989 | 0.03% | 152 |
|
|
2025
Q4 | $1.25M | Sell |
11,117
-130
| -1% | -$15.2K | 0.04% | 146 |
|
|
2025
Q3 | $1.43M | Sell |
11,247
-50
| -0.4% | -$6.94K | 0.04% | 123 |
|
|
2025
Q2 | $1.64M | Sell |
11,297
-24
| -0.2% | -$3.61K | 0.05% | 115 |
|
|
2025
Q1 | $1.75M | Buy |
11,321
+27
| +0.2% | +$3.97K | 0.06% | 101 |
|
|
2024
Q4 | $1.58M | Sell |
11,294
-385
| -3% | -$54.7K | 0.06% | 109 |
|
|
2024
Q3 | $1.57M | Sell |
11,679
-201
| -2% | -$25.5K | 0.06% | 108 |
|
|
2024
Q2 | $1.41M | Sell |
11,880
-515
| -4% | -$62.9K | 0.06% | 107 |
|
|
2024
Q1 | $1.52M | Hold |
12,395
| – | – | 0.06% | 111 |
|
|
2023
Q4 | $1.48M | Buy |
12,395
+242
| +2% | +$28.7K | 0.07% | 111 |
|
|
2023
Q3 | $1.4M | Buy |
12,153
+20
| +0.2% | +$2.41K | 0.07% | 109 |
|
|
2023
Q2 | $1.36M | Buy |
12,133
+19
| +0.2% | +$2.08K | 0.07% | 106 |
|
|
2023
Q1 | $1.39M | Buy |
12,114
+35
| +0.3% | +$3.98K | 0.07% | 104 |
|
|
2022
Q4 | $1.4M | Buy |
12,079
+7
| +0.1% | +$819 | 0.07% | 102 |
|
|
2022
Q3 | $1.35M | Sell |
12,072
-11
| -0.1% | -$1.36K | 0.07% | 99 |
|
|
2022
Q2 | $1.38M | Sell |
12,083
-13
| -0.1% | -$1.63K | 0.07% | 101 |
|
|
2022
Q1 | $1.65M | Buy |
12,096
+152
| +1% | +$18.7K | 0.09% | 96 |
|
|
2021
Q4 | $1.63M | Buy |
11,944
+381
| +3% | +$47.1K | 0.09% | 101 |
|
|
2021
Q3 | $1.3M | Sell |
11,563
-259
| -2% | -$29.1K | 0.08% | 102 |
|
|
2021
Q2 | $1.27M | Buy |
11,822
+459
| +4% | +$46.2K | 0.07% | 97 |
|
|
2021
Q1 | $1.11M | Buy |
11,363
+328
| +3% | +$30.2K | 0.07% | 97 |
|
|
2020
Q4 | $1.03M | Sell |
11,035
-4,190
| -28% | -$372K | 0.07% | 98 |
|
|
2020
Q3 | $1.22M | Buy |
15,225
+4,171
| +38% | +$313K | 0.1% | 89 |
|
|
2020
Q2 | $838K | Sell |
11,054
-139
| -1% | -$9.63K | 0.08% | 96 |
|
|
2020
Q1 | $705K | Sell |
11,193
-180
| -2% | -$14.4K | 0.07% | 102 |
|
|
2019
Q4 | $966K | Sell |
11,373
-240
| -2% | -$20.2K | 0.09% | 99 |
|
|
2019
Q3 | $961K | Buy |
+11,613
| New | +$965K | 0.09% | 109 |
|
|
2018
Q4 | – | Sell |
-2,788
| Closed | -$207K | – | 246 |
|
|
2018
Q3 | $207K | Sell |
2,788
-524
| -16% | -$37.7K | 0.02% | 224 |
|
|
2018
Q2 | $226K | Sell |
3,312
-1,065
| -24% | -$68.7K | 0.02% | 230 |
|
|
2018
Q1 | $270K | Buy |
+4,377
| New | +$289K | 0.02% | 204 |
|
|
2017
Q4 | – | Sell |
-6,466
| Closed | -$388K | – | 146 |
|
|
2017
Q3 | $388K | Sell |
6,466
-872
| -12% | -$49.8K | 0.03% | 149 |
|
|
2017
Q2 | $418K | Sell |
7,338
-20
| -0.3% | -$1.17K | 0.04% | 152 |
|
|
2017
Q1 | $433K | Sell |
7,358
-2,664
| -27% | -$162K | 0.04% | 154 |
|
|
2016
Q4 | $610K | Buy |
10,022
+282
| +3% | +$16.2K | 0.06% | 129 |
|
|
2016
Q3 | $564K | Sell |
9,740
-9,187
| -49% | -$551K | 0.06% | 132 |
|
|
2016
Q2 | $887K | Buy |
18,927
+8,589
| +83% | +$460K | 0.08% | 109 |
|
|
2016
Q1 | $558K | Buy |
+10,338
| New | +$521K | 0.05% | 130 |
|
Other funds holding PAYX
VCM
VPM
Aspiriant LLC's PAYX Position: Q1 2026 in Review
Aspiriant LLC reduced its Paychex (PAYX) stake by 0.09% in Q1 2026, selling an estimated $989 and leaving 11,107 shares worth $1.02M. The position accounts for 0.03% of the portfolio, ranked #152.
Aspiriant LLC first reported a position in PAYX in Q1 2016 and has held it in 37 quarters since. The position peaked at $1.75M in Q1 2025. 1,503 funds tracked by Wall St. Rank hold PAYX as of Q1 2026.
- Aspiriant LLC held 11,107 shares of Paychex worth $1.02M as of Q1 2026.
- Aspiriant LLC sold 10 Paychex shares in Q1 2026, an estimated $989.
- Paychex made up 0.03% of Aspiriant LLC's portfolio in Q1 2026, its #152 holding.
- Aspiriant LLC first reported a position in Paychex in Q1 2016 and has held it in 37 quarters since.
- Aspiriant LLC's Paychex position peaked at $1.75M in Q1 2025.
- 1,503 funds tracked by Wall St. Rank held Paychex as of Q1 2026.
Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.